Interestingly however, the presence of either one of these JP-45 variants decreased the sensitivity of the dihydropyridine receptor to activation. The presence of a JSRP1 variant may explain the variable phenotype seen in patients with malignant hyperthermia carrying the same mutation and more importantly, may counteract the hypersensitivity of excitation-contraction coupling caused by mutations in the RYR1 gene.
INTRODUCTION
Skeletal muscle excitation-contraction (EC) coupling is a physiological process whereby an electrical signal (depolarization of the plasma membrane) is converted into a chemical signal,
i.e. a calcium gradient, by the opening of ryanodine receptor (RyR1) Ca 2+ release channels located on the sarcoplasmic reticulum (SR) terminal cisternae. The Ca 2+ then binds to the contractile proteins to initiate muscle contraction; muscle relaxation occurs when the myoplasmic Ca 2+ is pumped back into the SR by the activity of the SERCA CaATPases (Fleischer and Inui, 1989; Rios and Pizarro, 1991; Franzini-Armstrong and Jorgensen, 1994) .
The two core components of the EC coupling machinery are the voltage sensing dihydropyridine receptor (DHPR) Ca 2+ channel located on the transverse tubules and the RyR1. Upon sensing a change in voltage the DHPR undergoes a conformational change whereby it directly interacts with and activates the RyR1, causing Ca 2+ release from the SR ( (Nakai et al., 1996; Sutko and Airey, 1996) . The activity of the DHPR can be measured electrophysiologically and is accompanied by a measurable intermembrane current, which is proportional to the movement of charged ions across the transverse tubular membrane (Schneider and Chandler, 1973; Adams et al., 1990) .
Several congenital neuromuscular disorders are linked to dysregulation of calcium homeostasis among which the subclinical myopathy Malignant Hyperthermia (MH; MIM# 145600), the congenital core myopathy Central core disease (CCD; MIM# 117000) and some forms of Multiminicore disease (MmD; MIM# 255320) Centronuclear myopathy (CNM; MIM# 160150) and Congenital fiber type disproportion (Treves et al., 2008 , Jungbluth et al., 2011 Wilmhurst et al., 2011; Clarke et al., 2010) . Though more than 200 mutations in the RYR1 gene have been identified in patients belonging to these disease categories (Robinson et al., 2006; 5 Jungbluth et al., 2011; Duarte et al., 2011) , analysis of other genes encoding proteins involved in EC coupling have so far identified only mutations in CACNA1S, the gene encoding the α1 subunit (Ca v 1.1) of the skeletal muscle dihydropyridine receptor (DHPR) to be causatively linked to the pharmacogenetic disorder MH (Monnier et al., 1997; Stewart et al., 2001; Pirone et al., 2010; Toppin et al., 2010) . However mutations in these genes only accounts for approximately 70-80 % of the human cases and the search for mutations in other genes encoding proteins involved in EC coupling has so far yielded few if any true positive candidates.
Malignant Hyperthermia is a subtle pharmacogenetic disorder triggered by halogenated anesthetics and the muscle relaxant succinylcholine in genetically predisposed individuals (Glahn et al., 2010; Robinson et al., 2006; Treves et al., 2008) . In their everyday life such individuals are unaware of their condition though a small number of them may suffer from heat intolerance, muscle cramping after intense exercise and rhabdomyolysis; however, once such individuals come in contact with a trigger agent they undergo a rapid hypermetabolic reaction which is often fatal if left untreated. Thus, identifying potentially susceptible patients and their relatives prior to contact with a anesthesia is of utmost importance and the aim of clinical MHrelated research for non-invasive testing. In the past few years novel proteins of the SR have been identified and in many cases their ablation has been shown to affect Ca 2+ homeostasis and/or muscle performance. In previous studies we identified JP-45, an integral membrane protein of skeletal muscle SR junctional face membrane which interacts via its amino terminal with Ca v 1.1 and via its carboxy terminal, with the luminal calcium binding protein calsequestrin (Anderson et al., 2003 (Anderson et al., , 2006 . Three months old JP-45 mice showed decreased muscle strength, a decrease of the functional expression of the Ca v 1.1 and a decrease of depolarization-induced Ca 2+ release (Delbono et al., 2007) . These changes however, were no longer evident in old (>12 6 month old) JP-45 KO mice (Delbono et al., 2012 ). An initial study aimed at screening the JSRP1 of RYR1 mutations included in the EMHG guidelines as previously described (Girard et al. 2001) . MH testing was approved by the ethical board of the Basel University Hospital. The presence of the JSRP1 polymorphic variants was assayed on genomic DNA isolated either from whole blood or untreated muscle tissue using QIAamp DNA mini kit (Qiagen AG) following the manufacturers recommendations.
Identification of JSRP1 variants
The following primers and conditions were used to amplify JP-45 from genomic DNA: exon F 5'-ACAGAGCCAGTGACCACAGC-3' and R 5' -GAGGAATAGGCGCACAGGT-3'; exon 6 F 5'-GAGGGATGGACAGTGTGGAC-3' and R 5'-CTTTCCTTGGGGATGAAGGT-3'.
Amplification conditions were 1 cycle 95°C 4 min followed by 35 cycles annealing (65°C c.323C>T and 63°C for c.449G>C, 45 sec), extension (72°C, 40 sec), denaturation (95°C, 30 sec), followed by a 5 min extension cycle at 72°C. The PCR-amplified DNA fragments were purified using Qiagen PCR purification columns, digested with MspA1l (c.323C>T in exon 5) or AciI (c.449G>C in exon 6) run on a 15% acrylamide gel and visualized by ethidium bromide staining. The DNA mutation numbering system is based on the cDNA reference sequence, with +1 as the A of the initiator ATG codon..
Human myotube cultures and intracellular Ca 2+ measurements
primary skeletal muscle cultures were established from fragments of muscle biopsies obtained from patients undergoing diagnostic testing, as previously described (Ducreux et al., 2004) . Cells were cultured on 0.17 mm thick glass coverslips in growth medium and induced to differentiate into myotubes by culturing them in DMEM plus 4.5 mg/ml glucose, 0.5% BSA, 10 ng/ml EGF, 0.15 mg/ml creatine, 5 ng/ml insulin, 200 mM glutamine, 600 ng/ml penicillin G and streptomycin, and 7 mM HEPES, pH 7.4 for 7-10 days.
For cytoplasmic calcium measurements, coverslip grown myotubes were either loaded with the ratiometric fluorescent Ca 2+ indicator fura-2-AM or Fluo-4 AM (final concentration 5 µM) in differentiation medium for 30 min at 37°C, after which the coverslips were mounted onto a 37°C thermostatically controlled chamber which was continuously perfused with Krebs-Ringer 9 medium. On-line measurements were recorded using a fluorescent Axiovert S100 TV inverted microscope (Carl Zeiss GmbH, Jena, Germany) equipped with a 20x water-immersion FLUAR Hamamatsu CCD C9100-13 camera as previously described (Treves et al., 2010) . Changes in fluorescence were analyzed using Metamorph imaging system and the average pixel value for each cell was measured as previously described (Ducreux et al., 2004 , Treves et al., 2010 .
Individual cells were stimulated by means of a 12-or 8-way 100 mm diameter quartz micromanifold computer controlled microperfuser (ALA Scientific instruments, Westbury N.Y.
U.S.A.), as previously described (Ducreux et al., 2004) .
Electroporation of muscles from JP-45 KO mice with the cDNA carrying the variants in exon 5 or exon 6
JP-45KO mice were used for plasmid electroporation according to DiFranco et al. (2006) .
Briefly, flexor digitorum brevis (FDB) muscles were injected with 5 µl of 2mg/ml hyaluronidase and injected 1 hour later with 20 µg DsRed-conjugated JP-45 mutants or wild-type cDNAs. Ten minutes later, two sterile, gold-plated acupuncture needles were placed under the skin on adjacent sides of the muscle. Twenty 100 V/cm, 20-ms square-wave pulses of 1-Hz frequency were applied to the muscle for one second each using a Grass stimulator (Grass S48; W.
Warwick, RI, USA).
Charge movement and calcium current recordings FDB muscle fibers were transferred to a small flow-through Lucite chamber positioned on a microscope stage. Fibers were continuously perfused with the external solution (see below) using a push-pull syringe pump. Only fibers exhibiting clean surface and lack of evidence of contracture were used for electrophysiological recordings. Muscle fibers were voltage-clamped using an Axopatch-200B amplifier (Molecular Devices) in the whole-cell configuration of the patch-clamp technique (Hamill et al., 1981; Delbono et al., 2007) . Patch pipettes were pulled from borosilicate glass (Boralex) using a Flaming Brown micropipette puller (P97, Sutter Instrument Co., Novato, CA) and then fire-polished to obtain electrode resistance ranging from 450 to 650 kΩ. In cell-attached the seal resistance was in the range of 1 to 4.5 GΩ (n = 50) and in the whole-cell configuration the values were between ~100 MΩ. Only experiments with resistance more than 100 MΩ were included in the analysis. TEA(tetraethylammonium hydroxide)-CH 3 SO 3 , 2 MgCl 2 , 2 CaCl 2 , 10 Na-HEPES and 0.001 tetrodotoxin (Delbono, 1992) . Solution pH was adjusted to 7.4 with CsOH. Both, the pipette and the bath solution, were selected based on the ease of membrane seal formation and cell stability over time. For charge movement recording, Ca 2+ current was blocked with the external solution containing 0.5 mM Cd 2+ and 0.3 mM La 3+ (Adams et al., 1990 ).
Whole-cell currents were acquired and filtered at 5 kHz with pCLAMP 10 software (Molecular Devices). A Digidata 1440A interface (Molecular Devices) was used for A-D conversion. Membrane current during a voltage pulse, P, was initially corrected by analog subtraction of linear components. The remaining linear components were digitally subtracted online using hyperpolarizing control pulses of one-quarter test pulse amplitude (-P/4 procedure) as previously described for mouse muscle fibers (Delbono, 1992) . Four control pulses were applied before the test pulse. Charge movements were evoked by 25 ms depolarizing pulses from the holding potential (-80 mV) to command potentials ranging from -70 to 60 mV with 10mV
interval. Intramembrane charge movement was calculated as the integral of the current in response to depolarizing pulses (charge on, Q on ) and is expressed per membrane capacitance (coulombs per farad). The complete blockade of the inward Ca conductance, V is the membrane potential, Vr is the reversal potential, and V1/2 is the halfactivation potential, z is the effective valence, F is the Faraday constant, R is the gas constant, and T is the absolute temperature.
Sarcoplasmic reticulum Ca 2+ release
Dissociated FDB fibers were loaded with Oregon Greeen Bapta-5N (OGB-5N) via the patch pipette as described (Jimenez-Moreno et al., 2008) . The dye was allowed to diffuse for 20-30 min before fiber stimulation and after attaining the whole-cell voltage-clamp configuration.
Intracellular OGB-5N transients were recorded using a Bio-Rad Radiance 2100 laser scanning confocal microscope (Zeiss, Oberkochen, Germany). Confocal microscopy allowed us to improve the signal/noise ratio under experimental conditions in which myoplasmic Ca 
Statistical analysis
Statistical analysis was performed using the Student's t test for paired samples; means were considered statistically significant when the P value was <0.05. The Origin computer program (Microcal Software, Inc., Northampton, MA, USA) was used for statistical analysis. Figure 1 shows the human and mouse JP-45 amino acid sequences and the location of the JSRP1 polymorphic variants. We first assessed the frequency of the JP-45 polymorphism in exon 5 and exon 6 in the Swiss MH population, by screening the genomic DNA of patients that had been tested genetically and phenotypically and classified as either MHN (MH negative), MHEh (MH equivocal with abnormal response to halothane) with mutation in RYR1, MHEh, with no identified mutation in RYR1 or MHS (MH susceptible) with a causative RYR1 mutation. Figure 2 (left panels) shows a schematic representation of the restriction sites generated by the presence of the c.323C>T substitution (top) and of the c.449G>C 6 (bottom). The panels on the right show PCR amplified DNA from individuals with and without the polymorphisms, after digestion with MspA1l (c.323C>T, exon 5) and Acil (c.449G>C exon 6) while the frequency distribution of the polymorphisms among the different individuals is shown in Table 1 . As indicated (i) the frequency of the two SNP is not different between individuals belonging to different groups and
RESULTS
(ii) the SNP in exon 6 is more frequent compared to that in exon 5. We also identified one MHN individual carrying both polymorphisms.
In order to verify if the JSRP1 variants influence the resting [Ca 2+ ] and sensitivity of the ryanodine receptor to KCl-induced Ca 2+ release, we loaded myotubes from MHN/MHE individuals with no RYR1 mutation, carrying either the p.P108L polymorphism (2 individuals), the p.G150A polymorphism (3 MHN and 3 MHE individuals), with either fura-2 or fluo-4 and studied general aspects of calcium homeostasis. Figure 3A shows that the resting [Ca 2+ ] i of individuals carrying the p.G150A polymorphism were slightly lower than those carrying either no polymorphism or the p.P108L. It is difficult to interpret if such small changes (<10% of the fura-2 fluorescence value) though statistically significant, could be the consequence of altered 14 EC coupling, in particular due to fine alterations of Ca v 1.1 function. We next assessed the response of these myotubes to different concentrations of KCl. As shown in Figure 3B the sensitivity to KCl was very similar in myotubes carrying the p.P108L and p.G150A polymorphism, with an EC 50 of 36.5±2.5 and 30.5±1.0, respectively but this was shifted to higher KCl concentrations compared to myotubes carrying no polymorphisms (EC 50 11.3±6.8),
however the peak calcium release induced by KCl or via direct pharmacological activation of the RyR1 with 600 µM 4-chloro-m-cresol, were not different ( Figure 3C ). (Table 2 ). These changes in charge movement were accompanied by significant changes in the voltage-dependence of the calcium current (Fig. 4B) . Half activation potential for p.P108L (22 ± 2.8 mV) and p.G150A (23 ± 3.1 mV) was found at more depolarized potentials than wild type JP-45 (2.2 ± 0.41). As the shift in charge movement and calcium current activation for the p.G150A and p.P108L variants was significantly shifted toward more positive potentials compared to wild type JP-45, we examined the voltagedependence of SR Ca 2+ release. Consistently, SR Ca 2+ release shows a ~18 mV shift toward more depolarized potentials induced by both JP-45 variants compared to JP-45 wild type (Fig.   15   4C and Table 2 ).
DISCUSSION
In the present paper we investigated the impact of two naturally occurring variants of JSRP1 on EC coupling and report that their presence downregulates the activity of the dihydropyridine receptor leading to a shift in its sensitivity to activation; thus the presence of Data points were fitted to a Boltzmann equation (Methods) and best fitting parameters are included in Table 2 (n = 8-14 fibers from 4-5 mice per group). B. Normalized Calcium current (I ca )-Vm. Data points were normalized to peak current as described (Methods) (n = 7-13 fibers per group from 4 mice per group). C. Normalized Oregon Green Bapta (OGB)-5N-Vm relationship (n = 8-11 fibers from 3-4 mice per group).
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